Alterations in Glutathione Levels and Apoptotic Regulators Are Associated with Acquisition of Arsenic Trioxide Resistance in Multiple Myeloma
Arsenic trioxide (ATO) has been tested in relapsed/refractory multiple myeloma with limited success. In order to better understand drug mechanism and resistance pathways in myeloma we generated an ATO-resistant cell line, 8226/S-ATOR05, with an IC50 that is 2–3-fold higher than control cell lines an...
Main Authors: | Matulis, Shannon M., Morales, Alejo A., Yehiayan, Lucy, Lee, Kelvin P., Cai, Yong, Boise, Lawrence H. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528737/ |
Similar Items
-
Dimethylarsinothioyl Glutathione
as a Metabolite in
Human Multiple Myeloma Cell Lines upon Exposure to Darinaparsin
by: Yehiayan, Lucy, et al.
Published: (2014) -
Dexamethasone treatment promotes Bcl-2-dependence in multiple myeloma resulting in sensitivity to Venetoclax
by: Matulis, Shannon M., et al.
Published: (2015) -
Arsenic trioxide alters the differentiation of mouse embryonic stem cell into cardiomyocytes
by: Rebuzzini, Paola, et al.
Published: (2015) -
Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways
by: DOUDICAN, NICOLE A., et al.
Published: (2012) -
The clinical activity of arsenic trioxide, ascorbic acid, ifosfamide and prednisone combination therapy in patients with relapsed and refractory multiple myeloma
by: Li, Xin, et al.
Published: (2015)